Distribution of the regulatory subunit of type II cAMP-dependent protein kinase in Y-79 retinoblastoma cells. Effect of butyrate
- PMID: 3528034
Distribution of the regulatory subunit of type II cAMP-dependent protein kinase in Y-79 retinoblastoma cells. Effect of butyrate
Abstract
An indirect immunofluorescence technique was employed to determine the intracellular distribution of the regulatory subunit of type II cyclic adenosine 3':5'-monophosphate-dependent protein kinase (RII) in Y-79 human retinoblastoma cells growing in monolayer culture. During the initial phases of growth (6 hr-6 days after seeding), RII was confined to the cytoplasmic areas of the Y-79 cells, seemingly, the Golgi apparatus. Treatment of cells for 3-5 days with 4 mM butyrate resulted in translocation of RII from cytoplasm to nuclei (mainly nucleoli) of cells. In a later stage of growth (24-day-old cultures), RII immunofluorescence was significantly decreased in all compartments within the untreated cells. In contrast, about 70% of the butyrate-treated cells yet showed nucleoli and/or cytoplasmic localization of RII at this stage. The nucleolar appearance of RII was parallel to the growth arrest and differentiation induced by butyrate.
Similar articles
-
Butyrate enhances the synthesis of interphotoreceptor retinoid-binding protein (IRBP) by Y-79 human retinoblastoma cells.J Cell Physiol. 1985 Aug;124(2):233-9. doi: 10.1002/jcp.1041240210. J Cell Physiol. 1985. PMID: 3900095
-
Effects of butyrate, retinol, and retinoic acid on human Y-79 retinoblastoma cells growing in monolayer cultures.J Natl Cancer Inst. 1984 Sep;73(3):649-54. J Natl Cancer Inst. 1984. PMID: 6590911
-
Dynamic distribution of the regulatory subunit of cAMP-dependent protein kinase type II in NIH 3T3 cells.Biochem Int. 1988 Apr;16(4):601-7. Biochem Int. 1988. PMID: 2839186
-
Nucleolar accumulation of cyclic adenosine 3':5'-monophosphate receptor proteins during regression of MCF-7 human breast tumor.Cancer Res. 1984 Aug;44(8):3554-60. Cancer Res. 1984. PMID: 6331652
-
Control of retinoblastoma cell growth by differentiating agents: current work and future directions.Anticancer Res. 1986 May-Jun;6(3 Pt B):465-73. Anticancer Res. 1986. PMID: 2427007 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical